CoChat

Pharmacogenetics of Apolipoprotein E Gene During Lipid-Lowering Therapy: Lipid Levels and Prevention of Coronary Heart Disease

Nieminen, Tuomo, Kähönen, Mika, Viiri, Leena E, Grönroos, Paula, Lehtimäki, Terho · 2008 · Pharmacogenomics
Cited by 77

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

A non-optimal plasma concentration of lipids is among the major modifiable risk factors of atherosclerosis. Therefore, the prevention of cardiovascular disease by means of lipid-lowering therapy with statins and other agents is of great importance for patient groups where a lifestyle change, for example, diet modification, does not lead to adequately reduced lipid levels. The response of low-density-lipoprotein cholesterol (LDL-C) levels to statin therapy is highly variable. This is partly attributed to hereditary variation in genes involved in pharmacokinetics, pharmacodynamics and lipid metabolism. The pharmacogenetics of lipid-lowering therapy have been investigated for more than 40 different genes. The gene for apolipoprotein E (APOE) has been the most frequently studied, particularly regarding the epsilon2/epsilon3/epsilon4 polymorphism. Those with the epsilon4 allele seem to have the poorest and those with the epsilon2 allele the strongest response to statins with regards to LDL-C levels. In addition, the epsilon2 carriers may reach the LDL-C treatment goals more frequently than epsilon4 carriers. Few studies have investigated the interaction of the APOE epsilon2/epsilon3/epsilon4 polymorphism and lipid-lowering therapy in relation to the course of coronary heart disease; the results are contradictory and so far inconclusive. This review summarizes the pharmacogenetic findings related to the influence of APOE gene variation on lipid responses and the prevention of coronary heart disease during lipid-lowering therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2217/14622416.9.10.1475

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 73

  1. 10.1021/bi00727a022 · DOI · Paper page
  2. Boerwinkle E , UtermannG: Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.Am. J. Hum. Genet.42, 104–112 (1988).
  3. 10.1172/JCI113107 · DOI · Paper page
  4. 10.1161/01.ATV.18.9.1424 · DOI
  5. Zannis VI , JustPW, BreslowJL: Human apolipoprotein E isoprotein subclasses are genetically determined.Am. J. Hum. Genet.33, 11–24 (1981).
  6. 10.1016/S0021-9150(99)00501-8 · DOI
  7. 10.1353/hub.2008.0003 · doi:10.1353/hub.2008.0003
  8. 10.1016/S0022-2275(20)43170-0 · DOI · Paper page
  9. 10.1093/hmg/7.12.1887 · DOI · Paper page
  10. 10.1097/00001756-199903170-00038 · DOI · Paper page
  11. 10.1056/NEJM199511163332001 · DOI · Paper page
  12. 10.1016/S0140-6736(94)91755-8 · DOI · Paper page
  13. 10.1056/NEJM199610033351401 · DOI · Paper page
  14. 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
  15. 10.1586/14779072.6.4.447 · DOI
  16. 10.1016/S0021-9150(00)00383-X · DOI
  17. 10.3109/07853899109147932 · DOI
  18. 10.1515/CCLM.2007.116 · DOI · Paper page
  19. 10.1016/S0022-2275(20)38503-5 · DOI · Paper page
  20. 10.1016/0021-9150(86)90080-8 · DOI
  21. Werb Z , ChinJR, TakemuraR et al.: The cell and molecular biology of apolipoprotein E synthesis by macrophages. Ciba Found. Symp.118, 155–171 (1986).
  22. 10.1016/S0022-2275(20)40076-8 · DOI · Paper page
  23. 10.1172/JCI119887 · DOI · Paper page
  24. 10.1515/CCLM.2000.068 · doi:10.1515/cclm.2000.068
  25. 10.1111/j.1365-2265.2006.02455.x · DOI
  26. 10.1515/CCLM.2008.033 · DOI
  27. 10.1093/hmg/9.1.57 · DOI · Paper page
  28. 10.1038/sj.ejhg.5200983 · DOI
  29. 10.1016/j.clinbiochem.2006.02.002 · DOI
  30. 10.1016/j.clinbiochem.2007.06.010 · DOI
  31. 10.1038/ejhg.2008.27 · DOI
  32. 10.1161/01.CIR.100.6.608 · DOI · Paper page
  33. 10.1056/NEJM199404143301503 · DOI · Paper page
  34. 10.1161/01.ATV.21.5.832 · DOI
  35. 10.1111/j.1365-2796.1991.tb00464.x · DOI
  36. 10.1016/0026-0495(93)90066-W · DOI
  37. 10.1016/S0735-1097(00)00918-9 · DOI · Paper page
  38. 10.1007/s10038-006-0025-1 · DOI
  39. 10.1177/00912700122012643 · DOI
  40. 10.1016/j.amjcard.2003.06.008 · DOI
  41. 10.1038/sj.tpj.6500328 · DOI · Paper page
  42. 10.1016/0021-9150(94)05439-P · DOI · Paper page
  43. 10.1016/S0021-9150(96)06031-5 · DOI
  44. 10.2143/AC.61.3.2014836 · DOI
  45. 10.1097/FPC.0b013e3282f60aad · DOI
  46. 10.1111/j.1463-1326.2006.00577.x · DOI
  47. 10.1016/S0021-9150(01)00410-5 · DOI · Paper page
  48. 10.1097/00008571-200304000-00006 · DOI
  49. 10.1111/j.1365-2796.1993.tb00670.x · DOI · Paper page
  50. 10.1016/0026-0495(90)90068-N · DOI
  51. 10.1177/1074248406293732 · DOI
  52. 10.1016/0021-9150(90)90134-5 · DOI
  53. 10.1016/0168-8227(93)90018-Z · DOI
  54. 10.1046/j.1365-2796.2002.00991.x · DOI
  55. 10.1046/j.1365-2362.2002.00996.x · DOI
  56. 10.1185/030079907X199817 · DOI
  57. 10.1161/01.CIR.101.12.1366 · DOI · Paper page
  58. 10.1097/00008571-200211000-00009 · DOI
  59. 10.1093/eurheartj/ehm196 · DOI
  60. 10.1080/00365510701297472 · DOI
  61. 10.1016/j.amjcard.2005.08.011 · DOI
  62. 10.1097/MOL.0b013e3280555083 · DOI
  63. 10.1097/MOL.0b013e328235a5a2 · DOI
  64. 10.1038/sj.tpj.6500384 · DOI · Paper page
  65. 10.1097/MOL.0b013e32825a6773 · DOI · Paper page
  66. 10.1371/journal.pone.0000097 · DOI · Paper page
  67. 10.1016/S0026-0495(98)90240-2 · DOI
  68. 10.1016/S0021-9150(01)00584-6 · DOI
  69. Ye P , ShangY, DingX: The influence of apolipoprotein B and E gene polymorphisms on the response to simvastatin therapy in patients with hyperlipidemia.Chin. Med. Sci. J.18, 9–13 (2003).
  70. 10.2174/1567205043480546 · doi:10.2174/1567205043480546
  71. 10.1016/j.cccn.2005.06.005 · DOI
  72. 10.1097/01213011-200504000-00005 · DOI
  73. 10.1016/j.phrs.2006.12.009 · DOI

Cited by

See all 77

Metadata

Authors
Nieminen, T., Kähönen, M., Viiri, L. E., Grönroos, P., & Lehtimäki, T.
Venue
Pharmacogenomics
Published
2008-10
Volume
9
Issue
10
Pages
1475-1486
ISSN
  • 1462-2416 (ISSN-L)
  • 1744-8042
OpenAlex
W2104465297
Cited by
77
References
19
FWCI
8.40
Type
journal article
Language
en
Open access
closed
Funders
  • Emil Aaltonen Foundation
  • Finnish Foundation of Cardiovascular Research
  • Medical Research Fund of Tampere University Hospital

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacogenetics of Apolipoprotein E Gene During Lipid-Lowering Therapy: Lipid Levels and Prevention of Coronary Heart Disease. https://app.cochat.ai/papers/10.2217/14622416.9.10.1475
The paper
Nieminen, T., Kähönen, M., Viiri, L. E., Grönroos, P., & Lehtimäki, T. (2008). Pharmacogenetics of Apolipoprotein E Gene During Lipid-Lowering Therapy: Lipid Levels and Prevention of Coronary Heart Disease. Pharmacogenomics. https://doi.org/10.2217/14622416.9.10.1475

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.